Drug Approval | October 05, 2023
Alembic received 6 USFDA approvals during Q2FY24
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
Subscribe To Our Newsletter & Stay Updated
